Robert LeBoyer
Stock Analyst at Noble Financial
(0.04)
# 4,816
Out of 5,090 analysts
430
Total ratings
27.1%
Success rate
-13%
Average return
Main Sectors:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Reiterated: Buy | $12 | $0.7442 | +1,512.47% | 45 | Sep 28, 2026 | |
| NNVC NanoViricides | Reiterated: Buy | $6 | $1.43 | +319.58% | 4 | Sep 24, 2026 | |
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $10 | $3.04 | +228.95% | 24 | Sep 23, 2026 | |
| MAIA MAIA Biotechnology | Reiterated: Buy | $14 | $1.18 | +1,086.44% | 24 | Sep 22, 2026 | |
| GOVX GeoVax Labs | Reiterated: Buy | $10 | $0.1859 | +5,279.24% | 27 | Sep 17, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $50 | $3.81 | +1,212.34% | 20 | Aug 13, 2026 | |
| NTRB Nutriband | Reiterated: Buy | $15 | $6.64 | +125.90% | 10 | Aug 12, 2026 | |
| NRSN NeuroSense Therapeutics | Reiterated: Buy | $180 | $2.13 | +8,350.70% | 8 | Aug 11, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $20 | $6.41 | +212.01% | 11 | Aug 10, 2026 | |
| CVKD Cadrenal Therapeutics | Reiterated: Buy | $45 | $0.9434 | +4,669.98% | 17 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $19.00 | +136.84% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $10 | $0.98 | +920.41% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.912 | +1,215.79% | 5 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $6.65 | +20.30% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $37 | $5.28 | +600.76% | 30 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.088 | n/a | 5 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.55 | n/a | 36 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.301 | n/a | 24 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.04 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $1.03 | n/a | 11 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.71 | $0.04 | n/a | 2 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $20 | $1.30 | n/a | 10 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $27 | $0.000001 | n/a | 7 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $4.23 | n/a | 8 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.74 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $14 | $1.35 | n/a | 7 | Jan 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.77 | n/a | 2 | Dec 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.4935 | n/a | 6 | Dec 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 5 | Nov 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.83 | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.04 | n/a | 8 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.19 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.34 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.86 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $1 | $26.38 | n/a | 2 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.22 | n/a | 3 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.06 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.01 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.90 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 4 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $54 → $41 | $20.76 | n/a | 2 | Aug 5, 2016 |
Ocugen
Sep 28, 2026
Reiterated: Buy
Price Target: $12
Current: $0.7442
Upside: +1,512.47%
NanoViricides
Sep 24, 2026
Reiterated: Buy
Price Target: $6
Current: $1.43
Upside: +319.58%
Eledon Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $10
Current: $3.04
Upside: +228.95%
MAIA Biotechnology
Sep 22, 2026
Reiterated: Buy
Price Target: $14
Current: $1.18
Upside: +1,086.44%
GeoVax Labs
Sep 17, 2026
Reiterated: Buy
Price Target: $10
Current: $0.1859
Upside: +5,279.24%
Unicycive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $3.81
Upside: +1,212.34%
Nutriband
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $6.64
Upside: +125.90%
NeuroSense Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $180
Current: $2.13
Upside: +8,350.70%
Gyre Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $6.41
Upside: +212.01%
Cadrenal Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $0.9434
Upside: +4,669.98%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $19.00
Upside: +136.84%
May 27, 2026
Reiterated: Buy
Price Target: $6 → $10
Current: $0.98
Upside: +920.41%
May 22, 2026
Reiterated: Buy
Price Target: $12
Current: $0.912
Upside: +1,215.79%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $6.65
Upside: +20.30%
Mar 16, 2026
Reiterated: Buy
Price Target: $70 → $37
Current: $5.28
Upside: +600.76%
Jun 27, 2025
Rated: Hold
Price Target: n/a
Current: $0.088
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.55
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.301
Upside: n/a
Jan 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $5
Current: $2.04
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $8 → $9
Current: $1.03
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.71
Current: $0.04
Upside: n/a
May 14, 2021
Reiterated: Buy
Price Target: $20 → $20
Current: $1.30
Upside: n/a
Feb 9, 2021
Reiterated: Buy
Price Target: $18 → $27
Current: $0.000001
Upside: n/a
Jan 26, 2021
Reiterated: Buy
Price Target: $6 → $15
Current: $4.23
Upside: n/a
Jan 25, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $1.74
Upside: n/a
Jan 24, 2021
Reiterated: Buy
Price Target: $6 → $14
Current: $1.35
Upside: n/a
Dec 28, 2020
Downgraded: Hold
Price Target: n/a
Current: $4.77
Upside: n/a
Dec 24, 2020
Reiterated: Buy
Price Target: $6
Current: $0.4935
Upside: n/a
Nov 12, 2020
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Oct 5, 2020
Downgraded: Hold
Price Target: n/a
Current: $8.83
Upside: n/a
May 28, 2020
Reiterated: Buy
Price Target: $5
Current: $2.04
Upside: n/a
Feb 18, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $1.19
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $3.34
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $3.86
Upside: n/a
Apr 10, 2018
Downgraded: Hold
Price Target: $17 → $1
Current: $26.38
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $4.22
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $2.06
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.01
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.90
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 5, 2016
Downgraded: Hold
Price Target: $54 → $41
Current: $20.76
Upside: n/a